尚荣医疗：预计2025年全年扣非后净利润亏损1.36亿元至1.86亿元

Core Viewpoint - Shangrong Medical is expected to report a net profit loss of 136 million to 186 million yuan for the full year of 2025, primarily due to adverse industry conditions and operational challenges [1] Group 1: Performance Forecast - The company anticipates a net profit loss of 136 million to 186 million yuan after deducting non-recurring items for the year 2025 [1] - The decline in performance is attributed to a reduction in hospital engineering projects and corresponding service revenue [1] Group 2: Financial Results - For the first three quarters of 2025, the company's main revenue was 754 million yuan, a year-on-year decrease of 24.85% [1] - The net profit attributable to shareholders was -35.13 million yuan, a year-on-year decline of 338.5% [1] - The non-recurring net profit was -42.33 million yuan, a year-on-year decrease of 1336.59% [1] Group 3: Quarterly Performance - In Q3 2025, the company's single-quarter main revenue was 225 million yuan, down 39.25% year-on-year [1] - The single-quarter net profit attributable to shareholders was -27.37 million yuan, a year-on-year decline of 4004.28% [1] - The single-quarter non-recurring net profit was -29.81 million yuan, a year-on-year decrease of 2776.04% [1] Group 4: Financial Ratios and Other Metrics - The company's debt ratio stands at 23.31% [1] - Investment income reported was 10.20 million yuan, while financial expenses were -3.79 million yuan [1] - The gross profit margin is recorded at 14.35% [1]